DSpace

DSpace at RU >

Browsing by Author Roest, M.

Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 15 of 15
Full TextIssue DateTitleAuthor(s)
2010Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy.Mast, Q. de; Groot, P.G. de; Heerde, W.L. van; Roestenberg, M.; Velzen, J.F. van, et al
2009Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.Popa, C.; Tits, L.J.H. van; Barrera Rico, P.; Lemmers, H.L.M.; Hoogen, F.H.J. van den, et al
2008Paraoxonase (PON1) is associated with familial combined hyperlipidemia.Himbergen, TM van; Tits, L.J.H. van; Avest, E. ter; Roest, M.; Voorbij, H.A., et al
2008Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.Himbergen, TM van; Schouw, Y.T. van der; Voorbij, H.A.; Tits, L.J.H. van; Stalenhoef, A.F.H., et al
2006HFE mutations and risk of coronary heart disease in middle-aged women.A, D.L. van der; Peeters, P.H.; Grobbee, D.E.; Roest, M.; Marx, J.J.M., et al
2006Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women.A, D.L. van der; Marx, J.J.M.; Grobbee, D.E.; Kamphuis, M.H.; Georgiou, N.A., et al
2006Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.Laat, B. de; Derksen, R.H.W.M.; Mackie, I.J.; Roest, M.; Schoormans, S.C.M., et al
2006High-throughput genotyping with infrared fluorescence allele specific hybridization (iFLASH): a simple, reliable and low-cost alternative.Himbergen, T. van; Voorbij, H.A.; Barendrecht, A.D.; Rijn, B.B. van; Brambilla, R., et al
2006The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine.Himbergen, T. van; Tits, L.J.H. van; Roest, M.; Stalenhoef, A.F.H.
2005Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia.Himbergen, T. van; Tits, L.J.H. van; Hectors, M.P.C.; Graaf, J. de; Roest, M., et al
2005The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.Himbergen, T. van; Tits, L.J.H. van; Voorbij, H.A.; Graaf, J. de; Stalenhoef, A.F.H., et al
2004Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers.Himbergen, T. van; Roest, M.; Waart, F. de; Graaf, J. de; Voorbij, H.A., et al
2004Indications for a contribution of paraoxonase type-1 to plasma high density lipoprotein levels in patients with familial hypercholesterolemiaHimbergen, T. van; Roest, M.; Graaf, J. de; Jansen, E.H.; Hattori, H., et al
2003Testing an Information MappingĀ® text: Does the method live up to the expectations?Jansen, C.J.M.; Korzilius, H.P.L.M.; Pair, R.G. le; Roest, M.
2002Een Information MappingĀ® -tekst getest. Worden de sterallures waargemaakt?Jansen, C.J.M.; Korzilius, H.P.L.M.; Pair, R.G. le; Roest, M.
Showing results 1 to 15 of 15

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback